![shutterstock_2658171737 [Converted]_Smaller.jpg](https://static.wixstatic.com/media/dcb143_8063f21dfa5b4fe6890ff40ca69c3d51~mv2.jpg/v1/fill/w_147,h_49,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/dcb143_8063f21dfa5b4fe6890ff40ca69c3d51~mv2.jpg)
Member Spotlight
Wendy Wright
Wendy Wright is a nationally recognized nurse practitioner, educator and advocate whose leadership has shaped the future of advanced practice nursing. As a dedicated supporter of PMAAPP's mission, she champions mentorship and equity in health care, particularly for underrepresented communities.
Her commitment to empowering the next generation reflects the core values that drive PMAAPP forward.
EARLY BIRD REGISTRATION ENDS SEPTEMBER 1!
INDUSTRY NEWS
Will recent FDA approval of a novel
nonopioid analgesic be a game changer?
Physician's Weekly
The Food and Drug Administration recently approved Journavx, a first-in-class oral, nonopioid, highly selective sodium channel blocker indicated as a treatment for adults with moderate to severe acute pain. Clinical data revealed that this agent is an effective, well-tolerated medicine without evidence of addictive potential, indicated for use with all types of moderate to sever acute pain.
